Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Effect of CPAP on insulin resistance in patients with obstructive sleep apnoea and type 2 diabetes.

Harsch IA, Hahn EG, Pour Schahin S.

Thorax. 2008 Apr;63(4):384-5; author reply 385. doi: 10.1136/thx.2007.090415. No abstract available.

PMID:
18364450
2.

[A 56-year-old man with cystic fibrosis and coeliac disease].

Lampert S, Pour Schahin S, Wiest GH, Hahn EG, Ficker JH.

Z Gastroenterol. 2007 Jul;45(7):612-4. German.

PMID:
17620226
3.

Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance.

Harsch IA, Wallaschofski H, Koebnick C, Pour Schahin S, Hahn EG, Ficker JH, Lohmann T.

Respiration. 2004 Nov-Dec;71(6):580-6.

PMID:
15627868
4.

Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment.

Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, Ficker JH.

Eur Respir J. 2003 Aug;22(2):251-7.

5.

Reproducibility of a standardized titration procedure for the initiation of continuous positive airway pressure therapy in patients with obstructive sleep apnoea.

Wiest GH, Fuchs FS, Harsch IA, Pour Schahin S, Lampert S, Brueckl WM, Hahn EG, Ficker JH.

Respiration. 2001;68(2):145-50.

PMID:
11287828

Supplemental Content

Loading ...
Support Center